AIRS Medical nabs FDA clearance for AI MRI recon software

South Korean startup AIRS Medical has secured clearance from the U.S. Food and Drug Administration (FDA) for its artificial intelligence (AI)-based MRI reconstruction software.

SwiftMR uses deep learning trained with high-quality MRI images to improve low-quality images. AIRS Medical launched SwiftMR in South Korea in July; the software has been used with more than 4,000 patients since then, according to the firm.

The company plans to highlight SwiftMR at the upcoming RSNA meeting, it said.